2024

19/09/2024

Investor Presentation – Pitt Street Research Life Sciences Conference

08/07/2024

Shares In Value Interview with ASX: PIQ Managing Director

24/06/2024

Proteomics International Inks Deal With Eurobio Scientific for French Distribution of Kidney Test – 360Dx

24/06/2024

Proteomics seals kidney disease test supply deal in France – The West Australian

17/06/2024

Proteomics engages Growth Medics to expand PromarkerD test reach in EU – Medical Device Network

17/06/2024

Proteomics boosts European presence with diabetes device – The West Australian

24/05/2024

Dr Borehams’s Crucible: Proteomics International Labs – Biotech Daily

16/05/2024

Breakthrough in fight against chemically resistant dieback – Curtin University

16/05/2024

Proteomics tech emerges as early dieback diagnosis key

28/03/2024

Investor Presentation

25/03/2024

Proteomics International Inks Deal With Oxford for Endometriosis Samples – 360Dx

25/03/2024

Proteomics teams with Oxford university for endometriosis study – The West Australian

11/03/2024

The future of Endometriosis care – Phoenix Sound By Kel Myers

06/03/2024

Proteomics gets green light to continue diagnostic mission – The West Australian

29/02/2024

Proteomics stress test stamped with European patent – The West Australian

06/02/2024

Investor presentation – Euroz Hartleys Healthcare Forum

01/02/2024

Proteomics takes forward step with blood test diagnosis – The West Australian

25/01/2024

Investor Presentation

14/01/2024

Screening for Oesophageal cancer, PromarkerEso – Healthy Living, 2GB

2023

31/12/2023

December Newsletter 2023

20/12/2023

Chile deal opens wider American markets for Proteomics – The West Australian

19/12/2023

Promising health news, PromarkerEndo – ABC Perth Drive

18/12/2023

Endometriosis Diagnostic, PromarkerEndo – Channel 7 News Perth 4pm & 6pm

14/12/2023

Learning from UK’s kidney disease crisis – Medical Forum Magazine

23/11/2023

AGM Chairman’s Address and Investor Presentation

22/11/2023

The Perth health-tech company batting well above its average – 6PR Perth Radio, Money News

22/11/2023

Proteomics on a game-changing path to address kidney disease – AusBiz

22/11/2023

Proteomics nails US pricing milestone for diabetes test – The West Australian

16/11/2023

Bell Potter Healthcare Conference

30/10/2023

Investor Presentation – Non-deal Roadshow

20/10/2023

Chronic kidney disease with Dr Richard Lipscombe – Channel 9 News Perth 5pm bulletin

09/10/2023

As kidney disease reaches critical levels, doctors urge responsibility – 6PR Perth Radio

03/10/2023

Investor Webinar and Q&A session 3rd October 2023

29/09/2023

ASX Health Stocks: Proteomics soars 13pc after US sets price for PromarkerD – The Daily Telegraph

29/09/2023

US price locked in for Proteomics diabetes test – The West Australian

28/09/2023

Proteomics International Laboratories Ltd PromarkerD US Reimbursement Price & Aus Regulatory Decision – MarketScreener

27/09/2023

Proteomics develops new blood test for esophageal cancer – BioWorld

14/09/2023

Early diagnosis a step closer for those at risk of oesophageal cancer – BiotechDispatch

14/09/2023

Early detection for oesophageal cancer – Medical Forum

14/09/2023

Early Oesophageal Cancer Diagnosis Now Closer for At-Risk – Mirage News

10/09/2023

Proteomics International Laboratories Ltd (ASX:PIQ) New Oesophageal Cancer Test Presented At Global Conference – Menafn

08/09/2023

Proteomics International (ASX:PIQ) to present new oesophageal cancer test at global conference – The Market Herald

08/09/2023

Proteomics blood test primed for cancer fight – The West Australian

04/09/2023

Proteomics International Laboratories Ltd OxiDx Platform Technology Secures Patent in Japan – The West Australian